{
    "name": "StrategyBiotechNews",
    "symbol_sources": [
        {
            "asset_class": "us_equity",
            "sub_class": "biotech"
        }
    ],
    "data_providers": [
        {
            "asset_class": "us_equity",
            "data_type": "daily_ohlc",
            "provider": "polygon"
        },
        {
            "asset_class": "us_equity",
            "data_type": "news",
            "provider": "biopharmcatalyst"
        }
    ],
    "trade_config": {
        "starting_cash": 50000,
        "us_equity": {
            "type": "simple_fixed",
            /* allocate 1/4 of initial cash with each trade */
            "trade_size_in_dollars": 12500,
            "holding_period": "30_days"
        }
    },
    "specific_config": {
        "min_prev_daily_volume": 100000000,
        "max_prev_daily_volume": 100000000000,
        /* busted tickers, likely because of acq or failure */
        "blacklisted_symbols": [],
        "text_filters": [
            "fda",
            "approves",
            "accepts U.S. Food and Drug Administration",
            "trial",
            "study",
            "phase",
            "results",
            "findings",
            "appointment",
            "appoints",
            "board",
            "director",
            "executive",
            "officer",
            "present",
            "participate",
            "conference",
            "appointment",
            "appoints",
            "board",
            "director",
            "executive",
            "officer"
        ]
    },
}